1	Vascular	Vascular	B-NP	JJ	B-protein	4	NMOD	-1
2	endothelial	endothelial	I-NP	JJ	I-protein	4	NMOD	-1
3	growth	growth	I-NP	NN	I-protein	4	NMOD	0
4	factor-B	factor-B	I-NP	NN	I-protein	10	NMOD	-1
5	and	and	O	CC	O	10	NMOD	-1
6	vascular	vascular	B-NP	JJ	O	10	NMOD	-1
7	endothelial	endothelial	I-NP	JJ	O	10	NMOD	-1
8	growth	growth	I-NP	NN	O	10	NMOD	0
9	factor-C	factor-C	I-NP	NN	O	10	NMOD	-1
10	expression	expression	I-NP	NN	O	16	NMOD	9	expression
11	in	in	B-PP	IN	O	10	NMOD	-1
12	renal	renal	B-NP	JJ	O	14	NMOD	-1
13	cell	cell	I-NP	NN	O	14	NMOD	-1
14	carcinomas	carcinoma	I-NP	NNS	O	11	PMOD	-1
15	:	:	O	:	O	10	P	-1
16	regulation	regulation	B-NP	NN	O	0	ROOT	0
17	by	by	B-PP	IN	O	16	NMOD	-1
18	the	the	B-NP	DT	O	23	NMOD	-1
19	von	von	I-NP	NN	B-DNA	21	NMOD	-1
20	Hippel-Lindau	Hippel-Lindau	I-NP	NN	I-DNA	21	NMOD	-1
21	gene	gene	I-NP	NN	I-DNA	23	NMOD	-1
22	and	and	I-NP	CC	O	23	NMOD	-1
23	hypoxia	hypoxia	I-NP	NN	O	17	PMOD	-1
24	.	.	O	.	O	16	P	-1

1	Angiogenesis	Angiogenesis	B-NP	NN	O	2	SUB	3	Angiogenesis
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	essential	essential	B-ADJP	JJ	O	2	PRD	17	essential
4	for	for	B-PP	IN	O	3	AMOD	-1
5	tumor	tumor	B-NP	NN	O	6	NMOD	-1
6	growth	growth	I-NP	NN	O	8	NMOD	4	growth
7	and	and	I-NP	CC	O	8	NMOD	-1
8	metastasis	metastasis	I-NP	NN	O	4	PMOD	14	metastasis
9	.	.	O	.	O	2	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	regulated	regulate	I-VP	VBN	O	2	VC	0
4	by	by	B-PP	IN	O	3	VMOD	-1
5	numerous	numerous	B-NP	JJ	B-protein	7	NMOD	-1
6	angiogenic	angiogenic	I-NP	JJ	I-protein	7	NMOD	3	angiogenic
7	factors	factor	I-NP	NNS	I-protein	9	NMOD	-1
8	,	,	O	,	O	9	P	-1
9	one	one	B-NP	CD	O	4	PMOD	-1
10	of	of	B-PP	IN	O	9	NMOD	-1
11	the	the	B-NP	DT	O	13	NMOD	-1
12	most	most	I-NP	RBS	O	13	AMOD	-1
13	important	important	I-NP	JJ	O	10	PMOD	0
14	being	be	B-VP	VBG	O	13	NMOD	-1
15	vascular	vascular	B-NP	JJ	B-protein	18	NMOD	-1
16	endothelial	endothelial	I-NP	JJ	I-protein	18	NMOD	-1
17	growth	growth	I-NP	NN	I-protein	18	NMOD	0
18	factor	factor	I-NP	NN	I-protein	14	PRD	-1
19	(	(	O	(	O	21	DEP	-1
20	VEGF	VEGF	B-NP	NN	B-protein	21	DEP	-1
21	)	)	O	)	O	18	NMOD	-1
22	.	.	O	.	O	2	P	-1

1	Recently	Recently	B-NP	RB	O	10	NMOD	-1
2	VEGF-B	VEGF-B	I-NP	NN	B-protein	4	NMOD	-1
3	and	and	I-NP	CC	O	4	NMOD	-1
4	VEGF-C	VEGF-C	I-NP	NN	B-protein	10	NMOD	-1
5	,	,	O	,	O	10	P	-1
6	two	two	B-NP	CD	O	10	NMOD	-1
7	new	new	I-NP	JJ	O	10	NMOD	-1
8	VEGF	VEGF	I-NP	NN	B-protein	10	NMOD	-1
9	family	family	I-NP	NN	I-protein	10	NMOD	-1
10	members	member	I-NP	NNS	I-protein	12	SUB	-1
11	,	,	O	,	O	10	P	-1
12	have	have	B-VP	VBP	O	0	ROOT	-1
13	been	be	I-VP	VBN	O	12	VC	-1
14	identified	identify	I-VP	VBN	O	13	VC	-1
15	that	that	B-NP	WDT	O	14	VMOD	-1
16	bind	bind	B-VP	VBP	O	15	SBAR	15	bind
17	to	to	B-PP	TO	O	16	VMOD	-1
18	the	the	B-NP	DT	O	21	NMOD	-1
19	tyrosine	tyrosine	I-NP	NN	B-protein	21	NMOD	-1
20	kinase	kinase	I-NP	NN	I-protein	21	NMOD	-1
21	receptors	receptor	I-NP	NNS	I-protein	17	PMOD	-1
22	flt-1	flt-1	I-NP	NN	B-protein	33	NMOD	-1
23	(	(	O	(	O	25	DEP	-1
24	VEGFR1	VEGFR1	B-NP	NN	B-protein	25	DEP	-1
25	)	)	O	)	O	22	NMOD	-1
26	,	,	O	,	O	33	P	-1
27	KDR	KDR	B-NP	NN	B-protein	33	NMOD	-1
28	(	(	O	(	O	30	DEP	-1
29	VEGFR2	VEGFR2	B-NP	NN	B-protein	30	DEP	-1
30	)	)	O	)	O	27	NMOD	-1
31	,	,	O	,	O	33	P	-1
32	and	and	O	CC	O	33	NMOD	-1
33	flt-4	flt-4	B-NP	NN	B-protein	21	NMOD	-1
34	(	(	O	(	O	36	DEP	-1
35	VEGFR3	VEGFR3	B-NP	NN	B-protein	36	DEP	-1
36	)	)	O	)	O	33	NMOD	-1
37	.	.	O	.	O	12	P	-1

1	Although	Although	B-SBAR	IN	O	22	VMOD	-1
2	the	the	B-NP	DT	O	3	NMOD	-1
3	importance	importance	I-NP	NN	O	6	SUB	-1
4	of	of	B-PP	IN	O	3	NMOD	-1
5	VEGF-A	VEGF-A	B-NP	NN	B-protein	4	PMOD	-1
6	has	have	B-VP	VBZ	O	1	SBAR	-1
7	been	be	I-VP	VBN	O	6	VC	-1
8	shown	show	I-VP	VBN	O	7	VC	-1
9	in	in	B-PP	IN	O	8	VMOD	-1
10	renal	renal	B-NP	JJ	O	11	NMOD	-1
11	carcinomas	carcinoma	I-NP	NNS	O	9	PMOD	-1
12	,	,	O	,	O	22	P	-1
13	the	the	B-NP	DT	O	14	NMOD	-1
14	contribution	contribution	I-NP	NN	O	22	SUB	0
15	of	of	B-PP	IN	O	14	NMOD	-1
16	these	these	B-NP	DT	O	18	NMOD	-1
17	new	new	I-NP	JJ	O	18	NMOD	-1
18	ligands	ligand	I-NP	NNS	O	15	PMOD	-1
19	in	in	B-PP	IN	O	14	NMOD	-1
20	kidney	kidney	B-NP	NN	O	21	NMOD	-1
21	tumors	tumor	I-NP	NNS	O	19	PMOD	-1
22	is	be	B-VP	VBZ	O	0	ROOT	-1
23	not	not	O	RB	O	22	VMOD	-1
24	clear	clear	B-ADJP	JJ	O	22	PRD	-1
25	.	.	O	.	O	22	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	have	have	B-VP	VBP	O	0	ROOT	-1
3	,	,	O	,	O	2	P	-1
4	therefore	therefore	B-ADVP	RB	O	2	VMOD	-1
5	,	,	O	,	O	2	P	-1
6	measured	measure	B-VP	VBD	O	2	VMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	mRNA	mRNA	I-NP	NN	B-RNA	9	NMOD	0
9	level	level	I-NP	NN	O	6	OBJ	-1
10	of	of	B-PP	IN	O	9	NMOD	-1
11	VEGF-B	VEGF-B	B-NP	NN	B-protein	13	NMOD	-1
12	and	and	I-NP	CC	O	13	NMOD	-1
13	VEGF-C	VEGF-C	I-NP	NN	B-protein	10	PMOD	-1
14	together	together	B-ADVP	RB	O	15	PMOD	-1
15	with	with	B-PP	IN	O	6	VMOD	-1
16	their	their	B-NP	PRP$	O	17	NMOD	-1
17	receptors	receptor	I-NP	NNS	O	15	PMOD	-1
18	by	by	B-PP	IN	O	6	VMOD	-1
19	RNase	RNase	B-NP	NN	B-protein	21	NMOD	-1
20	protection	protection	I-NP	NN	O	21	NMOD	0
21	assay	assay	I-NP	NN	O	18	PMOD	-1
22	(	(	O	(	O	24	DEP	-1
23	RPA	RPA	B-NP	NN	B-protein	24	DEP	-1
24	)	)	O	)	O	21	NMOD	-1
25	in	in	B-PP	IN	O	6	VMOD	-1
26	26	26	B-NP	CD	O	29	NMOD	-1
27	normal	normal	I-NP	JJ	O	29	NMOD	-1
28	kidney	kidney	I-NP	NN	O	29	NMOD	-1
29	samples	sample	I-NP	NNS	O	34	NMOD	-1
30	and	and	O	CC	O	34	NMOD	-1
31	45	45	B-NP	CD	O	34	NMOD	-1
32	renal	renal	I-NP	JJ	O	34	NMOD	-1
33	cell	cell	I-NP	NN	O	34	NMOD	-1
34	cancers	cancer	I-NP	NNS	O	25	PMOD	-1
35	.	.	O	.	O	2	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	observed	observe	B-VP	VBD	O	0	ROOT	0
3	a	a	B-NP	DT	O	5	NMOD	-1
4	significant	significant	I-NP	JJ	O	5	NMOD	-1
5	up-regulation	up-regulation	I-NP	NN	O	15	NMOD	17	up-regulation
6	of	of	B-PP	IN	O	5	NMOD	-1
7	VEGF-B	VEGF-B	B-NP	NN	B-protein	6	PMOD	-1
8	(	(	O	(	O	12	DEP	-1
9	P	P	B-NP	NN	O	11	SUB	-1
10	=	=	B-VP	SYM	O	11	VMOD	-1
11	0.002	0.002	B-NP	CD	O	12	DEP	-1
12	)	)	O	)	O	5	NMOD	-1
13	but	but	B-NP	CC	O	15	NMOD	-1
14	not	not	I-NP	RB	O	13	DEP	-1
15	VEGF-C	VEGF-C	B-NP	NN	B-protein	2	OBJ	-1
16	(	(	O	(	O	20	DEP	-1
17	P	P	B-NP	NN	O	19	SUB	-1
18	=	=	B-VP	SYM	O	19	VMOD	-1
19	0.3	0.3	B-NP	CD	O	20	DEP	-1
20	)	)	O	)	O	15	NMOD	-1
21	in	in	B-PP	IN	O	15	NMOD	-1
22	neoplastic	neoplastic	B-NP	JJ	O	23	NMOD	-1
23	kidney	kidney	I-NP	NN	O	21	PMOD	-1
24	compared	compare	B-PP	VBN	O	2	VMOD	-1
25	with	with	B-PP	IN	O	24	PMOD	-1
26	normal	normal	B-NP	JJ	O	27	NMOD	-1
27	tissues	tissue	I-NP	NNS	O	25	PMOD	-1
28	.	.	O	.	O	2	P	-1

1	In	In	B-PP	IN	O	16	VMOD	-1
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	,	,	O	,	O	16	P	-1
4	although	although	B-SBAR	IN	O	16	VMOD	-1
5	VEGF	VEGF	B-NP	NN	B-protein	6	NMOD	-1
6	receptors	receptor	I-NP	NNS	I-protein	7	SUB	-1
7	were	be	B-VP	VBD	O	4	SBAR	-1
8	higher	high	B-ADJP	JJR	O	7	PRD	-1
9	in	in	B-PP	IN	O	8	AMOD	-1
10	tumors	tumor	B-NP	NNS	O	9	PMOD	-1
11	than	than	B-PP	IN	O	10	NMOD	-1
12	normal	normal	B-NP	JJ	O	13	NMOD	-1
13	kidney	kidney	I-NP	NN	O	11	PMOD	-1
14	,	,	O	,	O	16	P	-1
15	there	there	B-NP	EX	O	16	SUB	-1
16	was	be	B-VP	VBD	O	0	ROOT	-1
17	a	a	B-NP	DT	O	19	NMOD	-1
18	significant	significant	I-NP	JJ	O	19	NMOD	-1
19	up-regulation	up-regulation	I-NP	NN	O	30	NMOD	17	up-regulation
20	of	of	B-PP	IN	O	19	NMOD	-1
21	only	only	B-NP	JJ	O	22	NMOD	-1
22	flt-1	flt-1	I-NP	NN	B-protein	20	PMOD	-1
23	(	(	O	(	O	27	DEP	-1
24	P	P	B-NP	NN	O	26	SUB	-1
25	=	=	B-VP	SYM	O	26	VMOD	-1
26	0.003	0.003	B-NP	CD	O	27	DEP	-1
27	)	)	O	)	O	19	NMOD	-1
28	but	but	B-NP	CC	O	30	NMOD	-1
29	not	not	I-NP	RB	O	28	DEP	-1
30	KDR	KDR	B-NP	NN	B-protein	37	NMOD	-1
31	(	(	O	(	O	35	DEP	-1
32	P	P	B-NP	NN	O	35	DEP	-1
33	=	=	B-VP	SYM	O	32	NMOD	-1
34	0.12	0.12	B-NP	CD	O	33	AMOD	-1
35	)	)	O	)	O	30	NMOD	-1
36	or	or	O	CC	O	37	NMOD	-1
37	flt-4	flt-4	B-NP	NN	B-protein	16	PRD	-1
38	(	(	O	(	O	42	DEP	-1
39	P	P	B-NP	NN	O	42	DEP	-1
40	=	=	B-VP	SYM	O	39	NMOD	-1
41	0.09	0.09	B-NP	CD	O	40	AMOD	-1
42	)	)	O	)	O	37	NMOD	-1
43	.	.	O	.	O	16	P	-1

1	There	There	B-NP	EX	O	2	SUB	-1
2	was	be	B-VP	VBD	O	0	ROOT	-1
3	also	also	B-ADVP	RB	O	2	VMOD	-1
4	a	a	B-NP	DT	O	6	NMOD	-1
5	significant	significant	I-NP	JJ	O	6	NMOD	-1
6	correlation	correlation	I-NP	NN	O	2	PRD	-1
7	between	between	B-PP	IN	O	6	NMOD	-1
8	VEGF-C	VEGF-C	B-NP	NN	B-protein	10	NMOD	-1
9	and	and	O	CC	O	10	NMOD	-1
10	both	both	B-NP	DT	O	7	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	its	its	B-NP	PRP$	O	13	NMOD	-1
13	receptors	receptor	I-NP	NNS	O	21	NMOD	-1
14	flt-4	flt-4	I-NP	NN	B-protein	21	NMOD	-1
15	(	(	O	(	O	19	DEP	-1
16	P	P	B-NP	NN	O	18	SUB	-1
17	=	=	B-VP	SYM	O	18	VMOD	-1
18	0.006	0.006	B-NP	CD	O	19	DEP	-1
19	)	)	O	)	O	14	NMOD	-1
20	and	and	O	CC	O	21	NMOD	-1
21	KDR	KDR	B-NP	NN	B-protein	11	PMOD	-1
22	(	(	O	(	O	26	DEP	-1
23	P	P	B-NP	NN	O	25	SUB	-1
24	=	=	B-VP	SYM	O	25	VMOD	-1
25	0.03	0.03	B-NP	CD	O	26	DEP	-1
26	)	)	O	)	O	21	NMOD	-1
27	but	but	O	CC	O	2	VMOD	-1
28	no	no	B-NP	DT	O	29	NMOD	-1
29	association	association	I-NP	NN	O	27	AMOD	0
30	between	between	B-PP	IN	O	29	NMOD	-1
31	VEGF-B	VEGF-B	B-NP	NN	B-protein	35	NMOD	-1
32	and	and	O	CC	O	35	NMOD	-1
33	its	its	B-NP	PRP$	O	35	NMOD	-1
34	receptor	receptor	I-NP	NN	O	35	NMOD	-1
35	flt-1	flt-1	I-NP	NN	O	30	PMOD	-1
36	(	(	O	(	O	40	DEP	-1
37	P	P	B-NP	NN	O	39	SUB	-1
38	=	=	B-VP	SYM	O	39	VMOD	-1
39	0.23	0.23	B-NP	CD	O	40	DEP	-1
40	)	)	O	)	O	35	NMOD	-1
41	.	.	O	.	O	2	P	-1

1	A	A	B-NP	DT	O	3	NMOD	-1
2	significant	significant	I-NP	JJ	O	3	NMOD	-1
3	increase	increase	I-NP	NN	O	4	SUB	17	increase
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	observed	observe	I-VP	VBN	O	4	VC	0
6	in	in	B-PP	IN	O	5	VMOD	-1
7	flt-1	flt-1	B-NP	NN	B-protein	23	NMOD	-1
8	(	(	O	(	O	13	DEP	-1
9	P	P	B-NP	NN	O	13	DEP	-1
10	less	less	B-ADJP	JJR	O	9	NMOD	-1
11	than	than	B-PP	IN	O	10	AMOD	-1
12	0.001	0.001	B-NP	CD	O	11	PMOD	-1
13	)	)	O	)	O	7	NMOD	-1
14	,	,	O	,	O	23	P	-1
15	KDR	KDR	B-NP	NN	B-protein	23	NMOD	-1
16	(	(	O	(	O	20	DEP	-1
17	P	P	B-NP	NN	O	20	DEP	-1
18	=	=	B-VP	SYM	O	17	NMOD	-1
19	0.02	0.02	B-NP	CD	O	18	AMOD	-1
20	)	)	O	)	O	15	NMOD	-1
21	,	,	O	,	O	23	P	-1
22	and	and	O	CC	O	23	NMOD	-1
23	flt-4	flt-4	B-NP	NN	B-protein	31	NMOD	-1
24	(	(	O	(	O	28	DEP	-1
25	P	P	B-NP	NN	O	28	DEP	-1
26	=	=	B-VP	SYM	O	25	NMOD	-1
27	0.01	0.01	B-NP	CD	O	26	AMOD	-1
28	)	)	O	)	O	23	NMOD	-1
29	but	but	B-NP	CC	O	31	NMOD	-1
30	not	not	I-NP	RB	O	29	DEP	-1
31	VEGF-B	VEGF-B	B-NP	NN	B-protein	38	NMOD	-1
32	(	(	O	(	O	36	DEP	-1
33	P	P	B-NP	NN	O	36	DEP	-1
34	=	=	B-VP	SYM	O	33	NMOD	-1
35	0.82	0.82	B-NP	CD	O	34	AMOD	-1
36	)	)	O	)	O	31	NMOD	-1
37	or	or	O	CC	O	38	NMOD	-1
38	VEGF-C	VEGF-C	B-NP	NN	O	44	NMOD	-1
39	(	(	O	(	O	43	DEP	-1
40	P	P	B-NP	NN	O	43	DEP	-1
41	=	=	B-VP	SYM	O	40	NMOD	-1
42	0.52	0.52	B-NP	CD	O	41	AMOD	-1
43	)	)	O	)	O	38	NMOD	-1
44	expression	expression	B-NP	NN	O	6	PMOD	9	expression
45	in	in	B-PP	IN	O	44	NMOD	-1
46	clear	clear	B-NP	JJ	O	47	NMOD	-1
47	cell	cell	I-NP	NN	O	45	PMOD	-1
48	compared	compare	B-PP	VBN	O	5	VMOD	-1
49	with	with	B-PP	IN	O	48	PMOD	-1
50	chromophil	chromophil	B-NP	NN	O	54	NMOD	-1
51	(	(	O	(	O	53	DEP	-1
52	papillary	papillary	O	JJ	O	53	DEP	-1
53	)	)	O	)	O	50	NMOD	-1
54	carcinomas	carcinoma	B-NP	NNS	O	49	PMOD	-1
55	.	.	O	.	O	4	P	-1

1	No	No	B-NP	DT	O	3	NMOD	-1
2	significant	significant	I-NP	JJ	O	3	NMOD	-1
3	association	association	I-NP	NN	O	4	SUB	0
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	demonstrated	demonstrate	I-VP	VBN	O	4	VC	-1
6	between	between	B-PP	IN	O	5	VMOD	-1
7	VEGF-B	VEGF-B	B-NP	NN	B-protein	16	NMOD	-1
8	,	,	O	,	O	16	P	-1
9	VEGF-C	VEGF-C	B-NP	NN	B-protein	16	NMOD	-1
10	,	,	O	,	O	16	P	-1
11	flt-1	flt-1	B-NP	NN	B-protein	16	NMOD	-1
12	,	,	O	,	O	16	P	-1
13	KDR	KDR	B-NP	NN	B-protein	16	NMOD	-1
14	,	,	O	,	O	16	P	-1
15	and	and	O	CC	O	16	NMOD	-1
16	flt-4	flt-4	B-NP	NN	B-protein	26	NMOD	-1
17	with	with	B-PP	IN	O	16	NMOD	-1
18	patient	patient	B-NP	NN	O	19	NMOD	-1
19	sex	sex	I-NP	NN	O	17	PMOD	-1
20	,	,	O	,	O	26	P	-1
21	patient	patient	B-NP	NN	O	22	NMOD	-1
22	age	age	I-NP	NN	O	26	NMOD	-1
23	,	,	O	,	O	26	P	-1
24	or	or	O	CC	O	26	NMOD	-1
25	tumor	tumor	B-NP	NN	O	26	NMOD	-1
26	size	size	I-NP	NN	O	6	PMOD	-1
27	(	(	O	(	O	32	DEP	-1
28	P	P	B-NP	NN	O	32	DEP	-1
29	greater	great	B-ADJP	JJR	O	28	NMOD	-1
30	than	than	B-PP	IN	O	29	AMOD	-1
31	0.05	0.05	B-NP	CD	O	30	PMOD	-1
32	)	)	O	)	O	26	NMOD	-1
33	.	.	O	.	O	4	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	effect	effect	I-NP	NN	O	11	NMOD	16	effect
3	of	of	B-PP	IN	O	2	NMOD	-1
4	von	von	B-NP	NN	B-DNA	9	NMOD	-1
5	Hippel-Lindau	Hippel-Lindau	I-NP	NN	I-DNA	9	NMOD	-1
6	(	(	O	(	I-DNA	9	NMOD	-1
7	VHL	VHL	B-NP	NN	I-DNA	9	NMOD	-1
8	)	)	O	)	I-DNA	9	NMOD	-1
9	gene	gene	B-NP	NN	I-DNA	3	PMOD	-1
10	and	and	I-NP	CC	O	11	NMOD	-1
11	hypoxia	hypoxia	I-NP	NN	O	30	SUB	-1
12	on	on	B-PP	IN	O	11	NMOD	-1
13	VEGF-B	VEGF-B	B-NP	NN	B-protein	16	NMOD	-1
14	and	and	I-NP	CC	O	16	NMOD	-1
15	VEGF-C	VEGF-C	I-NP	NN	O	16	NMOD	-1
16	expression	expression	I-NP	NN	O	12	PMOD	9	expression
17	in	in	B-PP	IN	O	16	NMOD	-1
18	the	the	B-NP	DT	O	22	NMOD	-1
19	renal	renal	I-NP	JJ	B-cell_line	22	NMOD	-1
20	carcinoma	carcinoma	I-NP	NN	I-cell_line	22	NMOD	-1
21	cell	cell	I-NP	NN	I-cell_line	22	NMOD	-1
22	line	line	I-NP	NN	I-cell_line	17	PMOD	-1
23	786-0	786-0	B-NP	CD	O	22	NMOD	-1
24	transfected	transfecte	B-VP	VBN	O	22	NMOD	19	transfected
25	with	with	B-PP	IN	O	24	VMOD	-1
26	wild-type	wild-type	B-NP	JJ	O	29	NMOD	-1
27	and	and	I-NP	CC	O	29	NMOD	-1
28	mutant	mutant	I-NP	JJ	O	29	NMOD	-1
29	VHL	VHL	I-NP	NN	O	25	PMOD	-1
30	was	be	B-VP	VBD	O	0	ROOT	-1
31	determined	determine	I-VP	VBN	O	30	VC	-1
32	by	by	B-PP	IN	O	31	VMOD	-1
33	growing	grow	B-NP	VBG	B-cell_type	34	NMOD	1	growing
34	cells	cell	I-NP	NNS	I-cell_type	32	PMOD	-1
35	under	under	B-PP	IN	O	31	VMOD	-1
36	21	21	B-NP	CD	O	37	AMOD	-1
37	%	%	I-NP	NN	O	38	NMOD	-1
38	O2-	O2-	I-NP	NN	O	42	NMOD	-1
39	and	and	O	CC	O	42	NMOD	-1
40	0.1	0.1	B-NP	CD	O	41	AMOD	-1
41	%	%	I-NP	NN	O	42	NMOD	-1
42	O2	O2	I-NP	NN	O	35	PMOD	-1
43	.	.	O	.	O	30	P	-1

1	In	In	B-PP	IN	O	6	VMOD	-1
2	wild-type	wild-type	B-NP	JJ	B-cell_line	4	NMOD	-1
3	VHL	VHL	I-NP	NN	I-cell_line	4	NMOD	-1
4	cells	cell	I-NP	NNS	I-cell_line	1	PMOD	-1
5	,	,	O	,	O	6	P	-1
6	whereas	whereas	O	IN	O	27	VMOD	-1
7	VEGF-A	VEGF-A	B-NP	NN	B-protein	8	SUB	-1
8	was	be	B-VP	VBD	O	6	SBAR	-1
9	significantly	significantly	I-VP	RB	O	8	VMOD	-1
10	up-regulated	up-regulate	I-VP	VBN	O	8	VC	17	up-regulated
11	under	under	B-PP	IN	O	10	VMOD	-1
12	hypoxic	hypoxic	B-ADJP	JJ	O	11	PMOD	-1
13	compared	compare	B-PP	VBN	O	10	VMOD	-1
14	with	with	B-PP	IN	O	13	PMOD	-1
15	normoxic	normoxic	B-NP	JJ	O	16	NMOD	-1
16	conditions	condition	I-NP	NNS	O	14	PMOD	-1
17	(	(	O	(	O	22	DEP	-1
18	P	P	B-NP	NN	O	22	DEP	-1
19	less	less	B-ADJP	JJR	O	18	NMOD	-1
20	than	than	B-PP	IN	O	19	AMOD	-1
21	0.001	0.001	B-NP	CD	O	20	PMOD	-1
22	)	)	O	)	O	16	NMOD	-1
23	,	,	O	,	O	27	P	-1
24	expression	expression	B-NP	NN	O	27	SUB	9	expression
25	of	of	B-PP	IN	O	24	NMOD	-1
26	VEGF-C	VEGF-C	B-NP	NN	B-protein	25	PMOD	-1
27	was	be	B-VP	VBD	O	0	ROOT	-1
28	reduced	reduce	I-VP	VBN	O	27	VC	18	reduced
29	(	(	O	(	O	34	DEP	-1
30	P	P	B-NP	NN	O	34	DEP	-1
31	less	less	B-ADJP	JJR	O	30	NMOD	-1
32	than	than	B-PP	IN	O	31	AMOD	-1
33	0.002	0.002	B-NP	CD	O	32	PMOD	-1
34	)	)	O	)	O	28	VMOD	-1
35	.	.	O	.	O	27	P	-1

1	Nevertheless	Nevertheless	B-ADVP	RB	O	7	VMOD	-1
2	,	,	O	,	O	7	P	-1
3	the	the	B-NP	DT	O	4	NMOD	-1
4	repression	repression	I-NP	NN	O	7	SUB	18	repression
5	of	of	B-PP	IN	O	4	NMOD	-1
6	VEGF-C	VEGF-C	B-NP	NN	B-protein	5	PMOD	-1
7	was	be	B-VP	VBD	O	0	ROOT	-1
8	lost	lose	I-VP	VBN	O	7	VC	-1
9	in	in	B-PP	IN	O	8	VMOD	-1
10	mutant	mutant	B-NP	JJ	B-cell_line	13	NMOD	-1
11	VHL	VHL	I-NP	NN	I-cell_line	13	NMOD	-1
12	cell	cell	I-NP	NN	I-cell_line	13	NMOD	-1
13	lines	line	I-NP	NNS	I-cell_line	9	PMOD	-1
14	under	under	B-PP	IN	O	8	VMOD	-1
15	hypoxia	hypoxia	B-NP	NN	O	14	PMOD	-1
16	.	.	O	.	O	7	P	-1

1	In	In	B-PP	IN	O	0	ROOT	-1
2	contrast	contrast	B-NP	NN	O	3	NMOD	-1
3	VEGF-B	VEGF-B	I-NP	NN	O	4	SUB	-1
4	was	be	B-VP	VBD	O	1	SBAR	-1
5	not	not	I-VP	RB	O	4	VMOD	-1
6	regulated	regulate	I-VP	VBN	O	4	VC	16	regulated
7	by	by	B-PP	IN	O	6	VMOD	-1
8	VHL	VHL	B-NP	NN	B-protein	7	PMOD	-1
9	despite	despite	B-PP	IN	O	6	VMOD	-1
10	clear	clear	B-NP	JJ	O	11	NMOD	-1
11	up-regulation	up-regulation	I-NP	NN	O	9	PMOD	17	up-regulation
12	in	in	B-ADVP	FW	O	11	NMOD	-1
13	vivo	vivo	I-ADVP	FW	O	12	AMOD	-1
14	.	.	O	.	O	1	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	findings	finding	I-NP	NNS	O	4	SUB	-1
3	strongly	strongly	B-ADVP	RB	O	4	VMOD	-1
4	support	support	B-VP	VBP	O	0	ROOT	0
5	an	an	B-NP	DT	O	7	NMOD	-1
6	enhanced	enhance	I-NP	VBN	O	7	NMOD	0
7	role	role	I-NP	NN	O	4	OBJ	0
8	for	for	B-PP	IN	O	7	NMOD	-1
9	this	this	B-NP	DT	O	10	NMOD	-1
10	pathway	pathway	I-NP	NN	O	8	PMOD	0
11	in	in	B-PP	IN	O	7	NMOD	-1
12	clear	clear	B-NP	JJ	O	14	NMOD	-1
13	cell	cell	I-NP	NN	O	14	NMOD	-1
14	carcinomas	carcinoma	I-NP	NNS	O	11	PMOD	-1
15	by	by	B-PP	IN	O	4	VMOD	-1
16	regulating	regulate	B-VP	VBG	O	15	PMOD	16	regulating
17	angiogenesis	angiogenesis	B-NP	NN	O	19	NMOD	3	angiogenesis
18	and/or	and/or	I-NP	CC	O	19	NMOD	-1
19	lymphangiogenesis	lymphangiogenesis	I-NP	NN	O	16	OBJ	3	lymphangiogenesis
20	.	.	O	.	O	4	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	study	study	I-NP	NN	O	3	SUB	-1
3	shows	show	B-VP	VBZ	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	clear	clear	B-NP	JJ	O	7	NMOD	-1
6	cell	cell	I-NP	NN	O	7	NMOD	-1
7	tumors	tumor	I-NP	NNS	O	8	SUB	-1
8	are	be	B-VP	VBP	O	4	SBAR	-1
9	able	able	B-ADJP	JJ	O	8	PRD	-1
10	to	to	B-VP	TO	O	11	VMOD	-1
11	up-regulate	up-regulate	I-VP	VB	O	9	AMOD	0
12	angiogenic	angiogenic	B-NP	JJ	B-protein	15	NMOD	3	angiogenic
13	growth	growth	I-NP	NN	I-protein	15	NMOD	0
14	factor	factor	I-NP	NN	I-protein	15	NMOD	-1
15	receptors	receptor	I-NP	NNS	I-protein	11	OBJ	-1
16	more	more	B-ADVP	RBR	O	17	AMOD	-1
17	efficiently	efficiently	I-ADVP	RB	O	11	VMOD	-1
18	than	than	B-PP	IN	O	17	AMOD	-1
19	chromophil	chromophil	B-NP	NN	O	18	PMOD	-1
20	(	(	O	(	O	22	DEP	-1
21	papillary	papillary	B-ADVP	JJ	O	22	DEP	-1
22	)	)	O	)	O	19	NMOD	-1
23	,	,	O	,	O	8	P	-1
24	that	that	B-SBAR	IN	O	39	DEP	-1
25	clear	clear	B-NP	JJ	O	27	NMOD	-1
26	cell	cell	I-NP	NN	O	27	NMOD	-1
27	tumors	tumor	I-NP	NNS	O	28	SUB	-1
28	can	can	B-VP	MD	O	24	SBAR	-1
29	use	use	I-VP	VB	O	28	VC	0
30	pathways	pathway	B-NP	NNS	O	29	OBJ	0
31	independent	independent	B-ADJP	JJ	O	30	NMOD	0
32	of	of	B-PP	IN	O	31	AMOD	-1
33	VHL	VHL	B-NP	NN	B-protein	32	PMOD	-1
34	to	to	B-VP	TO	O	35	VMOD	-1
35	regulate	regulate	I-VP	VB	O	28	VMOD	16	regulate
36	angiogenesis	angiogenesis	B-NP	NN	O	35	OBJ	3	angiogenesis
37	,	,	O	,	O	39	P	-1
38	and	and	O	CC	O	39	DEP	-1
39	that	that	B-SBAR	IN	O	8	VMOD	-1
40	this	this	B-NP	DT	O	42	NMOD	-1
41	combined	combine	I-NP	VBN	O	42	NMOD	-1
42	regulation	regulation	I-NP	NN	O	43	SUB	0
43	may	may	B-VP	MD	O	39	SBAR	-1
44	account	account	I-VP	VB	O	43	VC	-1
45	for	for	B-PP	IN	O	44	VMOD	-1
46	their	their	B-NP	PRP$	O	49	NMOD	-1
47	more	more	I-NP	RBR	O	48	AMOD	-1
48	aggressive	aggressive	I-NP	JJ	O	49	NMOD	-1
49	phenotype	phenotype	I-NP	NN	O	45	PMOD	-1
50	,	,	O	,	O	49	P	-1
51	which	which	B-NP	WDT	O	49	NMOD	-1
52	suggests	suggest	B-VP	VBZ	O	51	SBAR	-1
53	that	that	B-SBAR	IN	O	52	VMOD	-1
54	targeting	target	B-VP	VBG	O	59	SUB	0
55	VEGFR1	VEGFR1	B-NP	NN	B-protein	54	OBJ	-1
56	(	(	O	(	O	58	DEP	-1
57	flt-l	flt-l	B-NP	NN	O	58	DEP	-1
58	)	)	O	)	O	55	NMOD	-1
59	may	may	B-VP	MD	O	53	SBAR	-1
60	be	be	I-VP	VB	O	59	VC	-1
61	particularly	particularly	B-ADJP	RB	O	62	AMOD	-1
62	effective	effective	I-ADJP	JJ	O	60	PRD	0
63	in	in	B-PP	IN	O	60	VMOD	-1
64	these	these	B-NP	DT	O	66	NMOD	-1
65	tumor	tumor	I-NP	NN	O	66	NMOD	-1
66	types	type	I-NP	NNS	O	63	PMOD	-1
67	.	.	O	.	O	3	P	-1

